Dr. Jie Tian is the founder and chief scientist of the Key Laboratory of Molecular Imaging, Chinese Academy of Sciences. His research interests are in the development and clinical translation of optical multimodality molecular imaging technologies and medical image artificial intelligence (AI) technologies. He integrated optical scattering tomography (OST, including bioluminescence tomography, fluorescence molecular tomography, and Cerenkov luminescence tomography), positron emission tomography, and X-ray computed tomography into one animal scanning system for in vivo simultaneous and highly sensitive visualization of multiple biochemical events at the cellular and molecular level. He firstly applied AI strategy for high resolution and high speed reconstruction of OST images in 2018. He facilitated the clinical translation and promotion of intraoperative near-infrared (NIR) fluorescence imaging technology and published the first clinical application of NIR-II fluorescence imaging for guiding liver cancer surgery in 2020. He developed various AI models and algorithms for medical image big data analysis, which were widely applied to assist tumor diagnosis, prognosis, and personalized treatment decision-making in clinic. He authored 10 academic monographs and over 400 peer-reviewed journal articles, including publications in IEEE Series, Nature Series, Journal of Clinical Oncology, Annals of Oncology, Gut, Lancet Digital Health, and many other journals. These publications received over 50,700 Google Scholar citations (H-index: 104). He has more than 100 granted patents in China and 12 patents in the United States. Some of these patents incubated enterprises that are manufacturing different types of optical molecular imaging devices, which has obtained 17 approvals from the National Medical Products Administration of China. He used to or currently is serving as the editorial board member of IEEE Transactions on Medical Imaging, IEEE Transactions on Biomedical Engineering, IEEE Journal of Biomedical and Health Informatics, European Journal of Nuclear Medicine and Molecular Imaging, European Radiology, EBioMedicine, and Photoacoustics. He is recognized internationally for the Fellow of IEEE, AAAS, AIMBE, IAMBE, SPIE, OSA, ISMRM, WMIS, and IAPR.